DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Exelon (Rivastigmine Tartrate) - Current Clinical Trials

 
 



Exelon Related Clinical Trials

Rivastigmine and Huperzine A as Treatments for Cocaine Dependence [Completed]

Rivastigmine as a Treatment for Methamphetamine Dependence [Completed]

A Double-Blind, Placebo-controlled Crossover Study of Repeat Rivastigmine Administration in Healthy Male Volunteers [Completed]

Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44 [Completed]

Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline [Completed]

Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD) [Completed]

A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease [Completed]

Exelon Patch and Combination With Memantine Comparative Trial [Completed]

Effects of Exercise and Rivastigmine on Quality of Life of Alzheimer's Disease Patients [Completed]

Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients [Recruiting]

Tolerability of Rivastigmine Before and After Switching From Oral Formulation to Transdermal Patch in Alzheimer's Dementia [Active, not recruiting]

Bioequivalence Study of Rivastigmine Capsules 1.5 mg of Dr.Reddy's Under Fed Conditions [Completed]

Bioequivalence Study of Rivastigmine 1.5 mg Capsules Under Fasting Conditions [Completed]

Rivastigmine in the Treatment of Postoperative Delirium: a Pilot Clinical Trial [Completed]

Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles [Active, not recruiting]

Rivastigmine Study in Adolescents With Down Syndrome [Completed]

A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA) [Completed]

Methylphenidate, Rivastigmine or Haloperidol in Hypoactive Delirium in Intensive Care Patients [Terminated]

Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD [Recruiting]

Mild Cognitive Impairment in Parkinson's Disease [Completed]

Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients [Terminated]

Clinical Effectiveness of 10 cm^2 Rivastigmine Patch in Patients With Alzheimer's Disease [Completed]

The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems [Completed]

Efficacy of Rivastigmine in Patients With Down Syndrome [Completed]

Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease [Completed]

Rivastigmine Patch Effect on the Post-operative Delirium in Patients at Risk of Dementia. [Completed]

Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease [Completed]

Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI [Recruiting]

Cognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After Rivastigmine [Active, not recruiting]

Rivastigmine for Intensive Care Unit (ICU) Delirium [Terminated]

Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease [Completed]

Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment [Terminated]

A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease [Completed]

Efficacy Study for Treatment of Dementia in Progressive Supranuclear Palsy [Recruiting]

Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease [Completed]

Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury and Cognitive Impairment [Completed]

Rivastigmine Capsules in Patients With Probable Vascular Dementia [Completed]

Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia [Completed]

Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors [Completed]

16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients [Recruiting]

Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson&Apos;s Disease [Recruiting]

Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20) [Completed]

Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm� in Patients With Probable Alzheimer's Disease. [Completed]

RIVastigmine In Vascular cognitivE Impairment [Completed]

Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment [Terminated]

An Extension Study Evaluating the Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury (TBI) With Persistent Cognitive Deficits [Completed]

Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment [Completed]

Rivastigmine in Mild Alzheimer's Disease, FMRI Study [Completed]

Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia [Completed]

Rivastigmine in the Management of Delirium [Active, not recruiting]

Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study [Completed]

Rivastigmine For Methamphetamine Dependent Individuals [Completed]

Rivastigmine for the Prevention of Postoperative Delirium in Patients Undergoing Cardiac Surgery [Completed]

Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx) [Completed]

Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease [Completed]

An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease [Completed]

Cognitive Decline in Non-demented PD [Recruiting]

Comparative Research of Alzheimer's Disease Drugs [Active, not recruiting]

Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease [Completed]

Treatment of Orthostatic Hypotension in Autonomic Failure [Recruiting]

Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease [Active, not recruiting]

Neuromodulation and Language Acquisition (Stage Ib) [Suspended]

Neuromodulation and Language Acquisition (Project Stage Ia) [Terminated]

Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease [Completed]

Efficacy and Tolerability of MLC601 in Patients With Mild to Moderate Alzheimer Disease Who Were Unable to Tolerate or Failed to Benefit From Treatment With Rivastigmine [Completed]

Electrophysiologic Measures of Treatment Response in Alzheimer Disease [Completed]

Pharmacovigilance in Gerontopsychiatric Patients [Recruiting]

MAyflOwer RoAD Study: A Study of RO4602522 in Patients With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy [Active, not recruiting]

Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease [Completed]

A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease [Recruiting]

Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease [Completed]

Mifepristone as Adjunctive Therapy in Alzheimer's Disease [Terminated]

A Survey Study of the Treatment and Outcome Management in Patients Diagnosed With Alzheimer's Disease [Completed]

A Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease [Completed]

Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease [Terminated]

Use of Alternative Medicine in Patients With Dementia and Mild Cognitive Dysfunction [Completed]

Cilostazol Augmentation Study in Dementia [Completed]

Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly [Recruiting]

Electroconvulsive Therapy for Treatment of Alzheimer�s Disease [Not yet recruiting]

Enhancing Motor Task Training by Action Observation Watching Others Perform the Task [Completed]

Clinical Trial of Donepezil Between the Naive Group and the Switching Group [Recruiting]

Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012) [Recruiting]

The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-AD [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015